Mycophenolic acid inhibits syncytium formation accompanied by reduction of gp120 expression

Journal of Antibiotics

Volumn 58, Issue 8, 2005, Pages 514-518

  Ui, Hideaki ^b   Asanuma, Satoshi ^b   Chiba, Harumi ^b   Takahashi, Atsushi ^a   Yamaguchi, Yuichi ^a,b   Masuma, Rokuro ^a,b   Omura, Satoshi ^a,b   Tanaka, Haruo ^a  

^a KITASATO INSTITUTE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

AIDS; Fusion; gp120; HIV; Mycophenolic acid; Syncytium formation

Indexed keywords

BETA GALACTOSIDASE; GLYCOPROTEIN GP 120; GUANOSINE; GUANOSINE TRIPHOSPHATE; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION; SYNCYTIUM; VIRUS INHIBITION; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 25144433831     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2005.69     Document Type: Article

References (16)

1. Chiba H, Asanuma S, Okamoto M, Inokoshi J, Tanaka H, Fujita K, Ōmura S. A simple screening system for anti-HIV drugs: syncytium formation assay using T-cell line tropic and macrophage tropic HIV env expressing cell lines-establishment and validation. J Antibiot 54: 818-826 (2001)
2. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Baker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized double-blind, clinical studied in prevention of rejection. Transplantation 63: 39-47 (1997)
3. Allison AC, Eugai EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47: 85-118 (2000)
4. Weigel G, Griesmacher A, Zuckermann AO, Laufer G, Mueller MM. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients. Clin Pharmacol Ther 69: 137-144 (2001)
5. Ichimura H, Levy JA. Polymerase substrate depletion: A novel strategy for inhibiting the replication of the human immunodeficiency virus. Virology 211: 554-560 (1995)
6. Chapuis AG, Rizzardi GP, D'Agostino C, Attinger A, Knabenhans C, Fleury S, Acha-Orbea H, Pantaleo G. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 6: 762-768 (2000)
7. Margolis D, Heredia A, Gaywee J, Oldach D, Drusano G, Redfield R. Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity. J Acquir Immune Defic Syndr 21: 362-370 (1999)
8. Hossain MM, Coull JJ, Drusano GL, Margolis DM. Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. Antiviral Res 55: 41-52 (2002)
9. Margolis DM, Kewn S, Coull JJ, Ylisastigui L, Turner D, Wise H, Hossain MM, Lanier ER, Shaw LM, Back D. The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA. J Acquir Immune Defic Syndr 31: 45-49 (2002)
10. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63 (1983)
11. Sokoloski JA, Sartorelli AC. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism. Mol Pharmacol 28: 567-573 (1985)
12. Sokoloski JA, Blair OC, Sartorelli AC. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5′-phosphate dehydrogenase. Cancer Res 46: 2314-2319 (1986)
13. Laurent AF, Dumont S, Poindron P, Muller CD. Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endotherial cells and to some substrates. Exp Hematol 24: 59-67 (1996)
14. Williams RH, Lively DH, DeLong DC, Cline JC, Sweeney MJ, Poore GA, Larsen SH. Mycophenolic acid: antiviral and antitumor properties. J Antibiot 21: 463-464 (1968)
15. Carter SB, Franklin TJ, Jones DF, Leonard BJ, Mills SD, Turner RW, Turner WB. Mycophenolic acid: an anti-cancer compound with unusual properties. Nature 223: 848-850 (1969)
16. Suzuki S, Kimura T, Ando K, Sawada M, Tamura G. Antitumor activity of mycophenolic acid. J Antibiot 22: 297-302 (1969)